View in EDS PDF Full Text

Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice.

Saved in:
Bibliographic Details
Title: Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice.
Authors: Ejaz A; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA., Martinez-Guino L; Endocrinology Section, Hospital Sant Joan de Déu, Barcelona, Spain., Goldfine AB; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA., Ribas-Aulinas F; Department of Biochemistry and Molecular Biology, Institute of Biomedicine, University of Barcelona, and CIBER Fisiopatología de la Obesidad y Nutrición, Barcelona, Spain., De Nigris V; Diabetes and Obesity Laboratory, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain., Ribó S; Endocrinology Section, Hospital Sant Joan de Déu, Barcelona, Spain., Gonzalez-Franquesa A; Diabetes and Obesity Laboratory, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain., Garcia-Roves PM; Diabetes and Obesity Laboratory, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain CIBERDEM, Barcelona, Spain Department of Physiological Sciences II, University of Barcelona, Barcelona, Spain., Li E; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA., Dreyfuss JM; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA Department of Biomedical Engineering, Boston University, Boston, MA., Gall W; Metabolon, Inc., Durham, NC., Kim JK; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA., Bottiglieri T; Institute of Metabolic Disease, Baylor Research Institute, Dallas, TX., Villarroya F; Department of Biochemistry and Molecular Biology, Institute of Biomedicine, University of Barcelona, and CIBER Fisiopatología de la Obesidad y Nutrición, Barcelona, Spain., Gerszten RE; Massachusetts General Hospital and Harvard Medical School, Boston, MA., Patti ME; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA clerin@fsjd.org mary.elizabeth.patti@joslin.harvard.edu., Lerin C; Endocrinology Section, Hospital Sant Joan de Déu, Barcelona, Spain clerin@fsjd.org mary.elizabeth.patti@joslin.harvard.edu.
Source: Diabetes [Diabetes] 2016 Apr; Vol. 65 (4), pp. 902-12. Date of Electronic Publication: 2016 Feb 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26858359
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ejaz+A%22">Ejaz A</searchLink>; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Martinez-Guino+L%22">Martinez-Guino L</searchLink>; Endocrinology Section, Hospital Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Goldfine+AB%22">Goldfine AB</searchLink>; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ribas-Aulinas+F%22">Ribas-Aulinas F</searchLink>; Department of Biochemistry and Molecular Biology, Institute of Biomedicine, University of Barcelona, and CIBER Fisiopatología de la Obesidad y Nutrición, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22De+Nigris+V%22">De Nigris V</searchLink>; Diabetes and Obesity Laboratory, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ribó+S%22">Ribó S</searchLink>; Endocrinology Section, Hospital Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Franquesa+A%22">Gonzalez-Franquesa A</searchLink>; Diabetes and Obesity Laboratory, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Roves+PM%22">Garcia-Roves PM</searchLink>; Diabetes and Obesity Laboratory, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain CIBERDEM, Barcelona, Spain Department of Physiological Sciences II, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Li+E%22">Li E</searchLink>; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Dreyfuss+JM%22">Dreyfuss JM</searchLink>; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA Department of Biomedical Engineering, Boston University, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Gall+W%22">Gall W</searchLink>; Metabolon, Inc., Durham, NC.<br /><searchLink fieldCode="AU" term="%22Kim+JK%22">Kim JK</searchLink>; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA.<br /><searchLink fieldCode="AU" term="%22Bottiglieri+T%22">Bottiglieri T</searchLink>; Institute of Metabolic Disease, Baylor Research Institute, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Villarroya+F%22">Villarroya F</searchLink>; Department of Biochemistry and Molecular Biology, Institute of Biomedicine, University of Barcelona, and CIBER Fisiopatología de la Obesidad y Nutrición, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gerszten+RE%22">Gerszten RE</searchLink>; Massachusetts General Hospital and Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Patti+ME%22">Patti ME</searchLink>; Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA clerin@fsjd.org mary.elizabeth.patti@joslin.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Lerin+C%22">Lerin C</searchLink>; Endocrinology Section, Hospital Sant Joan de Déu, Barcelona, Spain clerin@fsjd.org mary.elizabeth.patti@joslin.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372763%22">Diabetes</searchLink> [Diabetes] 2016 Apr; Vol. 65 (4), pp. 902-12. <i>Date of Electronic Publication: </i>2016 Feb 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372763 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1939-327X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200121797%22">00121797 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26858359
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2337/db15-1094
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 902
    Titles:
      – TitleFull: Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ejaz A
      – PersonEntity:
          Name:
            NameFull: Martinez-Guino L
      – PersonEntity:
          Name:
            NameFull: Goldfine AB
      – PersonEntity:
          Name:
            NameFull: Ribas-Aulinas F
      – PersonEntity:
          Name:
            NameFull: De Nigris V
      – PersonEntity:
          Name:
            NameFull: Ribó S
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Franquesa A
      – PersonEntity:
          Name:
            NameFull: Garcia-Roves PM
      – PersonEntity:
          Name:
            NameFull: Li E
      – PersonEntity:
          Name:
            NameFull: Dreyfuss JM
      – PersonEntity:
          Name:
            NameFull: Gall W
      – PersonEntity:
          Name:
            NameFull: Kim JK
      – PersonEntity:
          Name:
            NameFull: Bottiglieri T
      – PersonEntity:
          Name:
            NameFull: Villarroya F
      – PersonEntity:
          Name:
            NameFull: Gerszten RE
      – PersonEntity:
          Name:
            NameFull: Patti ME
      – PersonEntity:
          Name:
            NameFull: Lerin C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2016 Apr
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1939-327X
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Diabetes
              Type: main
ResultId 1